Handa Pharmaceuticals, Inc. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 59.036 million compared to TWD 50.129 million a year ago. Operating loss was TWD 74.695 million compared to TWD 91.270 million a year ago. Net loss was TWD 60.000 million compared to TWD 85.238 million a year ago. Basic loss per share was TWD 0.57 compared to TWD 0.82 a year ago.